Direct inhibition of testicular steroidogenesis and gonadotrophin receptor levels by [(imBzl)-D-His6, Pro9-NEt]GnRH and [D-Trp6, Pro9-NEt]GnRH, potent agonists of GnRH
- PMID: 6286508
- DOI: 10.1111/j.1365-2605.1982.tb00243.x
Direct inhibition of testicular steroidogenesis and gonadotrophin receptor levels by [(imBzl)-D-His6, Pro9-NEt]GnRH and [D-Trp6, Pro9-NEt]GnRH, potent agonists of GnRH
Abstract
The effects of [(imBzl)-D-His6, Pro9-NEt]GnRH and [D-Trp6, Pro9-NEt]GnRH on testicular function in rats was evaluated. In adult rats the administration of 0.01, 0.1 or 10 micrograms of either agonist induced rapid increases in serum LH, FSH and testosterone (T) levels which started to decline within several hours. Both agonists caused a decrease in testicular LH and FSH receptor concentrations. The testicular FSH receptor concentration started to decline earlier than the LH receptor concentration but, both reached their lowest levels by day 2 after the administration of the agonists. The recovery of FSH receptor content was slower than that of LH. The extrapituitary effects of the 2 agonists were investigated in immature hypophysectomized animals. Administration of hCG (5 IU daily) to hypophysectomized rats for 5 days caused an increase in serum T levels. Concomitant administration of either of the agonists (10 micrograms) inhibited the steroidogenic action of hCG. Administration of the agonists alone caused a reduction in testicular LH receptor concentration in hypophysectomized rats. Treatment of the hypophysectomized rats for 0-4 days suggested that the direct antitesticular action of the agonists requires 1-2 days to become evident.
Similar articles
-
Gonadotropin-releasing hormone and its agonist inhibit testicular luteinizing hormone receptor and steroidogenesis in immature and adult hypophysectomized rats.Endocrinology. 1980 Oct;107(4):908-17. doi: 10.1210/endo-107-4-908. Endocrinology. 1980. PMID: 6250797
-
Mice are insensitive to the antitesticular effects of luteinizing hormone-releasing hormone agonists.Endocrinology. 1983 Jan;112(1):331-5. doi: 10.1210/endo-112-1-331. Endocrinology. 1983. PMID: 6291919
-
The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.J Clin Endocrinol Metab. 1984 Feb;58(2):313-9. doi: 10.1210/jcem-58-2-313. J Clin Endocrinol Metab. 1984. PMID: 6198331
-
Effects of gonadotropin-releasing hormone receptor blockade on rat testicular gonadotropin and lactogen receptors, steroidogenesis, and responses to human chorionic gonadotropin stimulation.Endocrinology. 1985 Jan;116(1):281-7. doi: 10.1210/endo-116-1-281. Endocrinology. 1985. PMID: 2981066
-
Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.Prog Clin Biol Res. 1981;74:273-91. Prog Clin Biol Res. 1981. PMID: 6275404 Review.
Cited by
-
Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.J Endocrinol Invest. 1988 Jul-Aug;11(7):535-57. doi: 10.1007/BF03350179. J Endocrinol Invest. 1988. PMID: 2902123 Review. No abstract available.
-
Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty.Drugs. 1993 Apr;45(4):570-88. doi: 10.2165/00003495-199345040-00008. Drugs. 1993. PMID: 7684676 Review.
-
Sexual maturation of the hypothalamus: pathophysiological aspects and clinical implications.Acta Neurochir (Wien). 1985;75(1-4):23-42. doi: 10.1007/BF01406321. Acta Neurochir (Wien). 1985. PMID: 3993451
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources